- $438.79m
- $388.08m
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0 | 0.043 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 28.6 | 14.5 | 21.3 | 57.6 | 84.9 |
Operating Profit | -28.6 | -14.5 | -21.3 | -57.6 | -84.9 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -8.64 | -20.2 | -21.8 | -58.4 | -81.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | -8.64 | -20.2 | -21.8 | -58.4 | -81.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -8.64 | -20.2 | -21.8 | -58.4 | -81.4 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -8.52 | -20.2 | -34.4 | -58.4 | -81.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -9.55 | -1.43 | -0.306 | -0.301 | -0.379 |